R&D: First patient recruited in global AMD trial

29-04-2019

R&D: First patient recruited in global AMD trial

(Source: PharmaTimes 2019-04-30)

A global research trial involving a new treatment to tackle early stage dry age-related macular degeneration (AMD), which causes blindness, has been launched.

The first patient has been recruited in the Eastern region at the James Paget University Hospital in Norfolk.

The new treatment involves stimulating cells in the retina with light in a process called ‘photobiomodulation.’ The cells respond to light of certain wavelengths and are ‘reset’ by the treatment so they use energy more effectively, with the aim of stopping the cells from dying prematurely.

The study is being supported by the NIHR, and led locally by JPUH Clinical Director of Research, Professor Ben Burton, who is also a visiting professor at the University of East Anglia.

To continue reading this article please go to PharmaTimes

New Article